Changes in energy during treatment of depression: an analysis of duloxetine in double‐blind placebo‐controlled trials

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 1368-5031, Iss. 10, 2015-10 ,pp. : 1139-1148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Celecoxib for the treatment of mild‐to‐moderate depression due to acute brucellosis: a double‐blind, placebo‐controlled, randomized trial

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 4, 2015-08 ,pp. : 441-446

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic Review on the Efficacy of Fexofenadine in Seasonal Allergic Rhinitis: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Clinical Trials

By  

International Archives of Allergy and Immunology, Vol. 156, Iss. 1, 2011-03 ,pp. : 1-15

Karger

Access to resources Recommend Favorite

Expectancy in Double-Blind Placebo-Controlled Trials: An Example from Alcohol Dependence

By  

Psychotherapy and Psychosomatics, Vol. 78, Iss. 3, 2009-03 ,pp. : 167-171

Karger

Access to resources Recommend Favorite

Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial

By Frakes E.P.   Risser R.C.   Ball T.D.   Hochberg M.C.   Wohlreich M.M.  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2361-2372

Informa Healthcare

Access to resources Recommend Favorite